Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement.  Read the Press Release

Merger announcement.png

Press Release - click here

FAQ - click here

Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, consulting, and contract services.

Pluristyx consulting.jpg
Pluristyx services.jpg
Pluristyx cryopreservation.jpg
Pluristyx products.jpg
Pluristyx gene editing.png